|
FAM167B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.29830043885215E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.76060055423477E-10 |
| Normal-vs-Stage2 |
3.91899956930786E-10 |
| Normal-vs-Stage3 |
1.51960000138729E-09 |
| Normal-vs-Stage4 |
1.08620001881832E-09 |
| Stage1-vs-Stage2 |
9.401200E-01 |
| Stage1-vs-Stage3 |
9.433000E-01 |
| Stage1-vs-Stage4 |
6.359000E-01 |
| Stage2-vs-Stage3 |
9.072400E-01 |
| Stage2-vs-Stage4 |
6.242200E-01 |
| Stage3-vs-Stage4 |
6.446400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.46609946405363E-10 |
| Normal-vs-AfricanAmerican |
2.02750038980071E-11 |
| Normal-vs-Asian |
3.58009999423814E-09 |
| Caucasian-vs-AfricanAmerican |
3.974200E-01 |
| Caucasian-vs-Asian |
7.004000E-01 |
| AfricanAmerican-vs-Asian |
3.655800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
1.49000034532776E-10 |
| Male-vs-Female |
9.518400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.24430000001141E-06 |
| Normal-vs-Extreme_Weight |
1.28060007043018E-10 |
| Normal-vs-Obese |
1.00989994145095E-10 |
| Normal-vs-Extreme_Obese |
4.93427521064405E-12 |
| Normal_Weight-vs-Extreme_Weight |
1.221640E-01 |
| Normal_Weight-vs-Obese |
1.037600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.861300E-03 |
| Extreme_Weight-vs-Obese |
8.312000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.815560E-02 |
| Obese-vs-Extreme_Obese |
9.662300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.71289995918056E-09 |
| Normal-vs-Age(41-60Yrs) |
2.55351295663786E-15 |
| Normal-vs-Age(61-80Yrs) |
2.49089970871808E-10 |
| Normal-vs-Age(81-100Yrs) |
1.8712809080057E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.288400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.469400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.804900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.424400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.621430E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.834300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.85869994343102E-10 |
| Normal-VS-Type2 PRCC |
1.93860483221897E-11 |
| Normal-VS-KIRP CIMP |
3.74179999995672E-06 |
| Normal-VS-Unclassified PRCC |
1.48989709458647E-11 |
| Type1 PRCC-VS-Type2 PRCC |
3.340200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.962150E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.350150E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.462200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.270000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.632070E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.96079843870234E-11 |
| Normal-vs-N1 |
2.50239995391865E-09 |
| Normal-vs-N2 |
7.036900E-03 |
| N0-vs-N1 |
9.206600E-01 |
| N0-vs-N2 |
5.260400E-01 |
| N1-vs-N2 |
6.015200E-01 |
|
|
